These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16353958)

  • 1. In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride.
    Al-Saidan SM; Krishnaiah YS; Patro SS; Satyanaryana V
    AAPS PharmSciTech; 2005 Jul; 6(1):E14-21. PubMed ID: 16353958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug.
    Al-Saidan SM; Krishnaiah YS; Satyanarayana V; Bhaskar P; Karthikeyan RS
    Eur J Pharm Biopharm; 2004 Nov; 58(3):697-703. PubMed ID: 15451547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride.
    Krishnaiah YS; Karthikeyan RS; Gouri Sankar V; Satyanarayana V
    J Control Release; 2002 May; 81(1-2):45-56. PubMed ID: 11992677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of colon targeted drug delivery systems for mebendazole.
    Krishnaiah YS; Veer Raju P; Dinesh Kumar B; Bhaskar P; Satyanarayana V
    J Control Release; 2001 Nov; 77(1-2):87-95. PubMed ID: 11689262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate.
    Krishnaiah YS; Karthikeyan RS; Satyanarayana V
    Int J Pharm; 2002 Jul; 241(2):353-66. PubMed ID: 12100863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the development of colon-targeted delivery systems for celecoxib in the prevention of colorectal cancer.
    Krishnaiah YS; Satyanarayana V; Kumar BD; Karthikeyan RS
    J Drug Target; 2002 May; 10(3):247-54. PubMed ID: 12075826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of guar gum-based matrix tablets of rofecoxib for colonic drug delivery.
    Al-Saidan SM; Krishnaiah YS; Satyanarayana V; Rao GS
    Curr Drug Deliv; 2005 Apr; 2(2):155-63. PubMed ID: 16305416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the development of oral colon targeted drug delivery systems for metronidazole in the treatment of amoebiasis.
    Krishnaiah YS; Bhaskar Reddy PR; Satyanarayana V; Karthikeyan RS
    Int J Pharm; 2002 Apr; 236(1-2):43-55. PubMed ID: 11891069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guar gum-based sustained release diltiazem.
    Altaf SA; Yu K; Parasrampuria J; Friend DR
    Pharm Res; 1998 Aug; 15(8):1196-201. PubMed ID: 9706049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride.
    Mughal MA; Iqbal Z; Neau SH
    AAPS PharmSciTech; 2011 Mar; 12(1):77-87. PubMed ID: 21174179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil.
    Krishnaiah YS; Satyanarayana V; Dinesh Kumar B; Karthikeyan RS
    Eur J Pharm Sci; 2002 Aug; 16(3):185-92. PubMed ID: 12128173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies on guar gum based formulation for the colon targeted delivery of Sennosides.
    Momin M; Pundarikakshudu K
    J Pharm Pharm Sci; 2004 Sep; 7(3):325-31. PubMed ID: 15576012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the development of colon targeted oral drug delivery systems for ornidazole in the treatment of amoebiasis.
    Krishnaiah YS; Muzib YI; Rao GS; Bhaskar P; Satyanarayana V
    Drug Deliv; 2003; 10(2):111-7. PubMed ID: 12746057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of guar gum in the preparation of sustained-release matrix tablets.
    Khullar P; Khar RK; Agarwal SP
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1095-9. PubMed ID: 9876566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
    Varshosaz J; Tavakoli N; Kheirolahi F
    AAPS PharmSciTech; 2006 Mar; 7(1):E24. PubMed ID: 16584155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride.
    Toti US; Aminabhavi TM
    J Control Release; 2004 Mar; 95(3):567-77. PubMed ID: 15023467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro and in-vivo evaluation of mesalazine-guar gum matrix tablets for colonic drug delivery.
    Tuğcu-Demiröz F; Acartürk F; Takka S; Konuş-Boyunağa O
    J Drug Target; 2004 Feb; 12(2):105-12. PubMed ID: 15203904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets.
    Krishnaiah YS; Seetha Devi A; Nageswara Rao L; Bhaskar Reddy PR; Karthikeyan RS; Satyanarayana V
    J Pharm Pharm Sci; 2001; 4(3):235-43. PubMed ID: 11737989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of guar gum compression-coated 5-aminosalicylic acid tablets for colon-specific drug delivery.
    Krishnaiah YS; Satyanarayana S; Prasad YV
    Drug Dev Ind Pharm; 1999 May; 25(5):651-7. PubMed ID: 10219535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and in vitro evaluation of oral colon targeted drug delivery systems for tinidazole.
    Krishnaiah YS; Indira Muzib Y; Srinivasa Rao G; Bhaskar P; Satyanarayana V
    J Drug Target; 2002 Dec; 10(8):579-84. PubMed ID: 12683661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.